Advance Your Melanocortin Receptor Drug Discovery with Our High-Quality GPCR Stable Cell Lines
GPCRs represent the largest class of drug targets, with over 35% of FDA-approved drugs targeting these receptors. Their involvement in diverse physiological pathways makes them ideal for treating complex diseases. However, developing GPCR-targeted drugs requires robust preclinical models to assess ligand binding, signaling efficacy, and toxicity.
Melanocortin receptors (MCRs) are a subfamily of G protein-coupled receptors (GPCRs) critical for regulating physiological processes such as energy homeostasis, pigmentation, inflammation, and exocrine gland function. As druggable GPCRs, they have emerged as promising targets for treating obesity, metabolic disorders, skin diseases, and rare genetic conditions. Dysregulation of melanocortin receptor (MCR) signaling is linked to multiple pathologies, making these receptors focal points for innovative drug development.
There are five known members of the melanocortin receptor system, each with differing specificities for melanocortins.
| Member | Function | Disease | Application |
| MC1R | Regulates melanin synthesis,
immune & inflammatory responses | Pigmentation disorders,
Inflammatory conditions | Studying UV protection and melanocyte biology |
| MC2R | Adrenal cortex function and cortisol synthesis | Congenital adrenal hyperplasia | Adrenal function research, endocrine disorder studies |
| MC3R | Energy metabolism, appetite regulation, and immune homeostasis | Early-onset obesity | Obesity and inflammation research |
| MC4R | Energy balance | Severe early-onset obesity | Obesity drug screening and leptin pathway studies |
| MC5R | Regulates exocrine gland function and immune cell activity | Hypohidrosis, acne | Skin physiology and immunology studies |
Stable cell lines expressing functional melanocortin receptors (MCRs) provide consistent, reliable platforms for high-throughput screening (HTS), mechanistic studies, and lead optimization.
1) High-Throughput Screening (HTS): Enable rapid identification of hit compounds via ligand binding assays.
2) Signaling Pathway Analysis: Monitor cAMP to assess agonist/antagonist efficacy.
3) Toxicity and Safety Testing: Evaluate off-target effects in a controlled cellular environment.
4) Pharmacodynamic Studies: Model receptor desensitization, internalization, and long-term signaling effects.
Creative Biogene owns a proprietary technology platform for GPCR stable cell line construction. Our platform has successfully developed a number of functionally validated GPCR stable cell line products which cover various type of GPCR targets including melanocortin receptors (MCRs). These stable cell lines have undergone rigorous testing to ensure high GPCR expression, robust GPCR functional activity, free of contamination etc. Our validated stable cell lines provide the consistency and physiological relevance needed to advance your pipeline.
Product List
Product Applications
1) Academic research (e.g., signal transduction).
2) Pharmaceutical drug discovery (e.g., hit identification, lead optimization).
3) Contract research organizations (CROs) for preclinical assay development.
Highlights
1) High GPCR expression levels validated by real-time qPCR.
2) Functional responsiveness to known ligands (e.g., α-MSH).
3) Ready for immediate use in binding assays (e.g., cAMP experiments).
4) Contamination-free (e.g., mycoplasma, bacterial, fungi etc.).
5) Customization options for a preferred cell background.
6) Fast turnaround with full technical support.
Representative Data
1) High-level gene expression verified by QPCR
2) Robust receptor activity verified by cAMP Assay




3) Mycoplasma-free detected by PCR & MycoAlert kit

| MycoAlert Mycoplasma Detection Data |
| Luminescence | A Value | B Value | B/A ratio | Result |
| Negative Control | 2517 | 593 | 0.23560 | / |
| Positive Control | 21213 | 828334 | 39.04841 | / |
| HEK293-Human-MC1R | 9527 | 5974 | 0.62706 | Negative/- |
| HEK293-Human-MC3R | 8768 | 6018 | 0.68636 | Negative/- |
| HEK293-Human-MC4R | 18490 | 10262 | 0.55500 | Negative/- |
| HEK293-Human-MC5R | 9438 | 5445 | 0.57692 | Negative/- |
4) Cell Morphology

HEK293-Human-MC1R(4X)

HEK293-Human-MC1R(10X)

HEK293-Human-MC3R(4X)

HEK293-Human-MC3R(10X)

HEK293-Human-MC4R(4X)

HEK293-Human-MC4R(10X)

HEK293-Human-MC5R(4X)

HEK293-Human-MC5R(10X)
* For research use only. Not intended for any clinical use.